Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking
The outbreak of viral pneumonia caused by the novel coronavirus SARS-CoV-2 that began in December 2019 caused high mortality. It has been suggested that the main protease (Mpro) of SARS-CoV-2 may be an important target to discover pharmaceutical compounds for the therapy of this life-threatening dis...
| Publié dans: | BioTechniques. - 1993. - 69(2020), 2 vom: 22. Aug., Seite 108-112 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | |
| Format: | Article en ligne |
| Langue: | English |
| Publié: |
2020
|
| Accès à la collection: | BioTechniques |
| Sujets: | Journal Article Research Support, Non-U.S. Gov't SARS-CoV-2 Mpro alliin molecular docking remdesivir ritonavir Antimalarials Antiviral Agents Viral Nonstructural Proteins plus... |
| Accès en ligne |
Volltext |